Аза Ахметовна Льянова
63 works · 47 citations · h-index 4
Top works
- EXPERIENCE OF USING PERTUZUMAB IN ANTICANCER THERAPY FOR HER2-POSITIVE BREAST CANCER
- The prospects for applications of cardiometric approach in evaluation of cardiotoxicity under Anthracyclines therapy in patients with breast cancer
- MOLECULAR BASIS OF MODERN TARGETED THERAPY FOR SQUAMOUS CELL CARCINOMA OF THE TONGUE AND ORAL MUCOSA WITH MONOCLONAL ANTIBODIES
- Epoetin alpha in the treatment of anemia in patients with malignant solid tumors during antitumor drug therapy
- Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis
- Dynamics of changes in expression of VEGF neoangiogenic factor in tumor tissue bioptates in patients with squamous cell carcinoma of oral mucosa receiving cetuximab treatment and chemotherapy
- Some aspects of nivolumab administration in treatment for metastatic melanoma (clinical cases)
- MORPHOFUNCTIONAL CHARACTERISTICS OF HEMATOPOIETIC TISSUE IN LYMPHOMA PATIENTS
- IMPACT OF VIRAL INFECTION ON EFFECTIVENESS OF ANTITUMOR TREATMENT FOR LARYNGEAL CANCER
- A study of prevalence of polymorphic variants of genes of blood coagulation factors in onco-logical patients
- Modern aspects of immunotherapy with checkpoint inhibitors in melanoma
- Nab-paсlitaxel (Nab-P) in patients with metastatic breast cancer (mBC) with visceral crisis (VC): Efficacy and tolerability.
- Cytokine profiles of peripheral blood in patients with non-small cell lung cancer receiving anti-PD1 therapy.
- Impact of viral infection on effectiveness of antitumor treatment for laryngeal cancer.
- Dynamics of changes in type 1 and 2 insulinlike growth factors in the blood of patients with oral squamous cell cancer after targeted therapy with cetuximab
- The effect of drug therapy and cetuximab on the mutational status of the KRAS gene in patients with squamous cell carcinoma of the tongue and oral floor mucosa
- STUDY OF VEGF-A AND TGF-Β LEVELS IN BIOPTATES OF SQUAMOUS CELL CARCINOMA OF THE TONGUE AND MOUTH FLOOR MUCOSA IN POLYCHEMOTHERAPY WITH MONOCLONAL ANTIBODIES – CETUXIMAB
- STUDY OF INSULIN-LIKE GROWTH FACTORS IN THE BLOOD OF PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE TONGUE AND LOWER ORAL MUCOSA RECEIVING THERAPY WITH MONOCLONAL ANTIBODIES - CETUXIMAB
- VEGF expression in cetuximab resistance development in patients with squamous cell carcinoma of the tongue and oral mucosa.
- Molecular mechanisms of resistance to monoclonal antibodies therapy patients with squamous cell carcinoma of the tongue and mucosa of the oral cavity